What Is a CT Scan for Cancer and What Can It Detect?

A CT scan is an imaging test that uses X-rays to create detailed cross-sectional pictures of the inside of your body, helping doctors find tumors, determine how far cancer has spread, and track whether treatment is working. It’s one of the most commonly ordered tests in cancer care, used at nearly every stage from initial detection through long-term follow-up.

How a CT Scan Works

A regular X-ray produces a flat, two-dimensional image where structures overlap each other. A CT scan solves this problem by taking many X-ray images from different angles as the machine rotates around your body. A computer then assembles those images into thin “slices,” much like slicing a loaf of bread. You can view each slice individually, or the software can stack them into a three-dimensional picture that lets doctors rotate and examine organs, bones, and soft tissues from any angle. This level of detail makes it possible to spot masses as small as a few millimeters and to see exactly where a tumor sits in relation to surrounding structures.

Why Doctors Order CT Scans for Cancer

CT scans serve several distinct purposes in cancer care, and the reason behind your scan shapes how it’s performed and what your doctor looks for.

Detection. When symptoms or a screening test raise suspicion, a CT scan can reveal whether a mass is present and where it’s located. Lung cancer screening programs, for example, rely on low-dose CT scans to catch tumors early in high-risk individuals.

Staging. Once cancer is confirmed, CT scans help determine how large the tumor is and whether it has spread to lymph nodes or distant organs. This information directly shapes the treatment plan.

Guiding biopsies. When a suspicious area is deep inside the body or can’t be felt during a physical exam, doctors use real-time CT images to guide a needle precisely into the mass and remove a tissue sample. This is called a CT-guided biopsy, and it allows pathologists to confirm whether cells are cancerous without surgery.

Monitoring treatment. During chemotherapy, immunotherapy, or radiation, repeat CT scans show whether tumors are shrinking, stable, or growing. These comparisons between scans over time are a key way oncologists decide if a treatment plan is working or needs to change.

What Contrast Agents Do

You may be asked to drink a liquid or receive an injection through an IV before your scan. These are contrast agents, and they make certain tissues show up more clearly on the images.

Oral contrast comes in two main types. Barium-based drinks coat the inside of your digestive tract, creating a bright white outline that separates bowel loops from nearby masses. Iodine-based oral solutions are used instead when there’s a concern about a tear or leak in the bowel, because iodine is safely absorbed by the body if it escapes the digestive tract. For cancers involving the bowel or the lining of the abdominal cavity, positive oral contrast helps doctors distinguish tumors from normal tissue that would otherwise look similar.

IV contrast, typically iodine-based, travels through your bloodstream and highlights blood vessels and highly vascular tissues. Tumors often have abnormal blood supply, so IV contrast can make them stand out against surrounding organs. If you’ve had an allergic reaction to contrast in the past or have kidney problems, let your care team know beforehand.

How CT Compares to Other Imaging

CT scans are particularly strong at imaging the lungs, bones, and abdomen. For lung lesions specifically, CT outperforms MRI. A study of 330 examinations published in the European Journal of Nuclear Medicine and Molecular Imaging confirmed that PET/CT was superior to PET/MRI for detecting lung metastases.

MRI, on the other hand, excels at soft tissue contrast and is often preferred for brain tumors, spinal cord involvement, and certain pelvic cancers. PET scans measure metabolic activity rather than structure, highlighting cells that are consuming energy at an unusually high rate, which is a hallmark of many cancers. PET and CT are frequently combined into a single PET/CT exam that shows both the metabolic behavior and the precise anatomical location of abnormal tissue. Your oncologist chooses the imaging tool, or combination, based on the type and location of the cancer in question.

What the Experience Is Like

CT scans are painless. You’ll lie on a motorized table that slides through a large, ring-shaped machine. Unlike an MRI, the opening is wide and shallow, so most people don’t feel claustrophobic. The actual scanning takes only a few minutes with modern machines, though the entire visit, including check-in, preparation, and any contrast administration, typically runs about 30 minutes.

You’ll be asked to hold very still during the scan because even small movements blur the images. In some cases, the technologist will ask you to hold your breath briefly. If you receive IV contrast, you may feel a warm flush or a metallic taste in your mouth for a few seconds. If you need to drink oral contrast, you’ll usually receive it 60 to 90 minutes before the scan to give it time to reach the right part of your digestive tract. Fasting for a few hours beforehand is common, but the specific instructions depend on what area of your body is being scanned.

Radiation Exposure

CT scans do involve radiation, and it’s reasonable to wonder about the risk, especially when cancer patients may need multiple scans over months or years. A chest CT delivers roughly 7 millisieverts (mSv) of radiation, and an abdominal CT about 8 mSv. For comparison, a standard chest X-ray delivers just 0.02 mSv, and the average American absorbs about 3 mSv per year from natural background radiation.

To put the cancer risk in perspective: the FDA estimates that a 10 mSv scan may increase the chance of a fatal cancer by about 1 in 2,000. Since the baseline risk of fatal cancer in the U.S. population is roughly 1 in 5 (or 400 in 2,000), a single scan shifts that number from 400 to about 401 in 2,000. For someone already diagnosed with cancer, the diagnostic value of the scan almost always far outweighs this small additional risk.

Limitations to Know About

CT scans are powerful, but they aren’t perfect. They show anatomy, not biology, so a mass that looks suspicious may turn out to be scar tissue, an infection, or a benign growth. This is why biopsies are still necessary to confirm a diagnosis. False-positive rates can be significant in screening contexts. In lung cancer screening trials, the rate of false positives per screening round was 23.3% in the U.S. National Lung Screening Trial and 10.4% in a large European trial. That means roughly one in four to one in ten flagged results turned out not to be cancer.

Very small tumors or microscopic spread (micrometastases) can also fall below what CT can detect. A scan showing no visible disease doesn’t guarantee cancer is completely absent, which is why doctors combine imaging with blood tests, physical exams, and clinical judgment.

Results and Turnaround Time

A radiologist reviews your images and sends a written report to your ordering physician. In emergency settings, the average time from completing the scan to a finalized report runs roughly two to three hours, though it can be longer depending on the facility’s workload. For outpatient cancer scans, results are typically available within one to three business days. Your oncologist will then compare the new images to prior scans, looking at tumor size, lymph node changes, and any new areas of concern before discussing the findings with you.

Cost and Insurance

CT scan prices in the U.S. range widely, from about $300 to $6,750 depending on the facility, geographic location, and whether contrast is used. Without insurance, expect to pay around $2,000 or more. Most insurance plans cover CT scans that are medically necessary for cancer diagnosis or monitoring, but many require prior authorization before they’ll pay. Even with coverage, you may still owe a copay, coinsurance, or deductible. Calling your insurance provider before the scan to confirm authorization and your expected out-of-pocket share can prevent surprise bills.